Tuesday, December 1, 2009

Tuesday, November 10, 2009

Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: behavioral and biochemical evidence

Summary: The present study points out towards the beneficial effect of epigallocatechin gallate in the amelioration of chronic fatigue syndrome and thus may provide a new, effective and powerful strategy to treat chronic fatigue syndrome.




Sachdeva, A. K. K., Kuhad, A., Tiwari, V., and Chopra, K. (2009). Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: behavioral and biochemical evidence. Behavioural brain research, 205(2):414-420. http://www.citeulike.org/user/HEIRS/article/5323625

















Thursday, November 5, 2009

Chronic Fatigue Syndrome groups call for better CDC research program

Chronic fatigue syndrome organisations have been calling for a major shake up of the Centers for Disease Control and Prevention's research program and now it seems on the back of the recent XMRV retrovirus breakthrough by a...
Click to read.

Wednesday, November 4, 2009

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) - Day 1- video

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) - Day 1

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) - Day 2 - Video

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) - Day 2

How Nurses Can Help Patients Manage Chronic Fatigue Syndrome

Oct. 29. 2009 - More than a million Americans suffer from chronic fatigue syndrome ― dealing with sleep, cognitive and physical symptoms that are often difficult to manage. While misperceptions have surrounded the disease, more health care professionals are beginning to recognize that they can help patients cope with the condition, manage symptoms and improve function and quality of life.  Click here.

Saturday, October 31, 2009

The Chronic Fatigue Syndrome Advisory Committee (CFSAC) - Fall, 2009

The Chronic Fatigue Syndrome Advisory Committee (CFSAC) fall session was held on October 29-30, 2009.  Among the speakers were Dr. Peterson from the Whittemore Peterson Institute and Dr. Coffin, a retrovirus expert, from Tufts University. The main topic of discussion was the discovery of a possible link between the XMRV retrovirus and chronic fatigue syndrome. It will be exciting what these new findings mean for patients with CFS and if these important research findings can be reproduced.  While this discovery is important, it is important to remember, these results are preliminary and XMRV may just be a "piggy-back" virus. Even Dr. Peterson acknowledged that other co-factors almost certainly may play a part in CFS. In the past, several other viruses have been suggested as causing CFS. Many believe that it may be a variety of factors that stimulate the disease and there may be no "smoking gun" for this condition. For everyone's sake, let's hope not because it makes it all that much harder to treat. On a positive note, these findings bring more attention to CFS and will bring more funding for research.

Resources: